We are live on ! Find out more
Appleton Partners

Appleton Partners Portfolio holdings

AUM $1.63B Turnover 4.32%
1-Year Est. Return 29.96%
 

Appleton Partners is an employee-owned investment firm that specializes in municipal bonds, taxable bonds and stocks for individuals, families and institutions. Douglas Chamberlain co-founded it in 1986 and is its president and chief executive. Before that he was a research director, portfolio manager and trust investment officer. Its custom portfolios serve families, charities and city or state governments. It also manages accounts for other advisers and financial firms. Its investment teams rely on fundamental analysis, backed by economic and technical insights.

This Fund
S&P 500
This Quarter Est. Return
+0.59%
1 Year Est. Return
+29.96%
3 Year Est. Return
+109.71%
5 Year Est. Return
+117.94%
10 Year Est. Return
+408.95%
AUM
$489M
AUM Growth
-$16.7M
Cap. Flow
-$15M
Cap. Flow %
-3.06%
Top 10 Hldgs %
23.12%
Holding
214
New
8
Increased
52
Reduced
123
Closed
10
Avg Time Held
2 years
Top 10 Avg Time Held
1.6 years
Top 20 Avg Time Held
1.7 years

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$3.94M
2
AGN
Allergan plc
AGN
+$3.03M
3
AMZN icon
Amazon
AMZN
+$2.76M
4
AVGO icon
Broadcom
AVGO
+$1.42M
5
DLTR icon
Dollar Tree
DLTR
+$1.18M

Top Sells

Rank Stock Value
1
APTV icon
Aptiv
APTV
+$4.25M
2
C icon
Citigroup
C
+$3.43M
3
UAA icon
Under Armour
UAA
+$1.91M
4
GILD icon
Gilead Sciences
GILD
+$1.44M
5
ROP icon
Roper Technologies
ROP
+$1.33M

Sector Composition

Rank Sector Weight
1 Healthcare 17.85%
2 Financials 15.07%
3 Technology 13.59%
4 Consumer Discretionary 11.59%
5 Consumer Staples 10.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
BIIB icon
101
Biogen
BIIB
$37.2B
$961K 0.2%
3,972
-321
-7% -$84.6K
2015 Q1
5 quarters
CCI icon
102
Crown Castle
CCI
$38B
$961K 0.2%
9,475
+4,320
+84% +$392K
2016 Q1
1 quarter
CVX icon
103
Chevron
CVX
$424B
$934K 0.19%
8,908
-675
-7% -$67.9K
2013 Q2
12 quarters
RSG icon
104
Republic Services
RSG
$77.9B
$926K 0.19%
18,050
+4,385
+32% +$210K
2015 Q4
2 quarters
CLX icon
105
Clorox
CLX
$13.3B
$916K 0.19%
6,616
+379
+6% +$49.1K
2015 Q2
4 quarters
APD icon
106
Air Products & Chemicals
APD
$69.9B
$865K 0.18%
6,584
– –
2014 Q3
7 quarters
BA icon
107
Boeing
BA
$131B
$845K 0.17%
6,509
– –
2013 Q2
12 quarters
UL icon
108
Unilever
UL
$144B
$841K 0.17%
15,596
+89
+0.6% +$4.57K
2015 Q3
3 quarters
EBAY icon
109
eBay
EBAY
$53.1B
$839K 0.17%
35,836
-3,311
-8% -$79.9K
2014 Q1
9 quarters
CELG
110
DELISTED
Celgene
CELG
$833K 0.17%
8,449
-1,614
-16% -$167K
2013 Q2
12 quarters
LLY icon
111
Eli Lilly
LLY
$1.28T
$784K 0.16%
9,955
-520
-5% -$39.1K
2014 Q4
6 quarters
CMCSA icon
112
Comcast
CMCSA
$90.9B
$679K 0.14%
20,834
-980
-4% -$30.4K
2015 Q4
2 quarters
SO icon
113
Southern Company
SO
$110B
$678K 0.14%
12,648
+144
+1% +$7.24K
2014 Q3
7 quarters
EW icon
114
Edwards Lifesciences
EW
$61.6B
$676K 0.14%
20,340
+8,130
+67% +$278K
2016 Q1
1 quarter
EFX icon
115
Equifax
EFX
$22.2B
$674K 0.14%
5,250
– –
2015 Q4
2 quarters
PX icon
116
DELISTED
Praxair
PX
$667K 0.14%
5,931
-102
-2% -$11.6K
2013 Q2
12 quarters
DD icon
117
DuPont de Nemours
DD
$19.9B
$658K 0.13%
5,227
+119
+2% +$15.7K
2014 Q2
8 quarters
BLK icon
118
Blackrock
BLK
$185B
$656K 0.13%
1,914
-45
-2% -$15.8K
2015 Q3
3 quarters
DHR icon
119
Danaher
DHR
$162B
$643K 0.13%
9,467
-1,042
-10% -$68.2K
2015 Q3
3 quarters
AMP icon
120
Ameriprise Financial
AMP
$44.6B
$637K 0.13%
7,095
-202
-3% -$19.5K
2015 Q3
3 quarters
OHI icon
121
Omega Healthcare
OHI
$14.3B
$621K 0.13%
18,297
-135
-0.7% -$4.5K
2015 Q1
5 quarters
ED icon
122
Consolidated Edison
ED
$45.2B
$619K 0.13%
7,695
-150
-2% -$11.3K
2013 Q2
12 quarters
IBM icon
123
IBM
IBM
$229B
$605K 0.12%
4,169
-43
-1% -$6.16K
2013 Q2
12 quarters
UAA icon
124
Under Armour
UAA
$2.08B
$600K 0.12%
14,952
-47,804
-76% -$1.91M
2015 Q2
4 quarters
CME icon
125
CME Group
CME
$114B
$598K 0.12%
6,142
+2,472
+67% +$234K
2016 Q1
1 quarter

Similar funds

Appleton Partners's Q2 2016 Portfolio in Review

As of Q2 2016, Appleton Partners held 214 positions worth $489M, down 3.3% from $506M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Appleton Partners withdrew a net $15M in Q2 2016, closing 10 positions and reducing 123 holdings. Its most notable exit was Perrigo, an estimated $412K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Financials and Technology.

Against the trend, Appleton Partners opened a new position in UnitedHealth worth $4.17M.

  • Appleton Partners's largest Q2 2016 buy was UnitedHealth: 29,523 shares worth $4.17M.
  • Appleton Partners added most to Allergan plc in Q2 2016, an estimated $3.03M increase.
  • Appleton Partners's biggest Q2 2016 reduction was Aptiv, cutting an estimated $4.25M.
  • Appleton Partners fully exited Perrigo in Q2 2016, selling an estimated $412K.
  • Appleton Partners's ten largest holdings make up 23% of its $489M portfolio in Q2 2016.
  • Appleton Partners opened 8 new positions and closed 10 in Q2 2016.
  • Appleton Partners's portfolio value fell 3.3% quarter-over-quarter to $489M.

Based on Appleton Partners's 13F filing for Q2 2016, filed 3 Aug 2016.